Diagnosis and therapeutic strategy for papillary thyroid microcarcinoma

Archives of Surgery

Volumn 140, Issue 10, 2005, Pages 940-945

  Lin, Jen Der ^a,b   Chen, Szu Tah ^a   Chao, Tzu Chieh ^a   Hsueh, Chuen ^a   Weng, Hsiao Fen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADULT; ARTICLE; ASPIRATION BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, PAPILLARY; ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 26844554591     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.140.10.940     Document Type: Article

References (28)

1. Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol. 2003;14:183-191.
2. Neuhold N, Kaiser H, Kaserer K. Latent carcinoma of the thyroid in Austria: a systemic autopsy study. Endocr Pathol. 2001;12:23-31.
3. Ottino A, Pianzola HM, Castelletto RH. Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer. 1989;64:547-551.
4. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid: a study of 408 autopsy cases. Cancer. 1990;65:1173-1179.
5. Lin KD, Lin JD, Huang HS, Jeng LB, Ho YS. Skull metastasis with brain invasion from thyroid papillary microcarcinoma: report of a case. J Formos Med Assoc. 1997;96:280-282.
6. Strate SM, Lee EL, Childer JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer. 1984;54:1093-1100.
7. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-953.
8. Sugino K, Ito K Jr, Ozaki O, Mimura T, Iwasaki H, Ito K. Papillary microcarcinoma of the thyroid. J Endocrinol Invest. 1998;21:445-448.
9. Harach HR, Fransilla KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a "normal" finding in Finland: a systematic autopsy study. Cancer. 1985;56:531-538.
10. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid: evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988;90:72-76.
11. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15:1033-1041.
12. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102:1088-1095.
13. Hay ID, Bergstralh EJ, Geollner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050-1058.
14. Lupoli G, Vitale G, Caraglia M, et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet. 1999;353:637-639.
15. Kwok CG, McDougall IR. Familial differentiated carcinoma of the thyroid: report of five pairs of siblings. Thyroid. 1995;5:395-397.
16. Hay ID, Grant CS, van Heerden JA, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139-1147.
17. van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112:1130-1138.
18. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Nature history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424.
19. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805-828.
20. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794-804.
21. Woolner LB. Thyroid carcinoma: pathologic classification with data on prognosis. Semin Nucl Med. 1971;1:481-502.
22. Schindler AM, van Melle G, Evequoz B, Scazziga B. Prognostic factors in papillary carcinoma of the thyroid. Cancer. 1991;68:324-330.
23. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31-40.
24. Ashcraft MW, van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med. 1981;71:806-814.
25. Lin JD, Huang MJ, Hsu BR, et al. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. J Surg Oncol. 2002;80:45-51.
26. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab. 1994;79:98-105.
27. Rios Zambudio A, Rodriguez Gonzalez JM, Sola Perez J, Soria Cogollos T, Galindo Fernandez PJ, Parilla Paricio P. Utility of frozen-section examination for diagnosis of malignancy associated with multinodular goiter. Thyroid. 2004;14:600-604.
28. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381-387.